c.kuipers
Submits third-party assay reports on material purchased directly. Based in Utrecht.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
98.87%
n=10
Suppliers covered
10
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043482 | BPC-157 | BCH | BCH-2603-L5474 | Janoshik | 2026-Q3 | 97.42 | 5.28 | — | Buyer-sourced | 0 | FAIL |
| AX-2026-043168 | BPC-157 | GL Biochem | GLBI-2602-T8050 | Janoshik | 2026-Q2 | 98.69 | 5.01 | 105.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042916 | Retatrutide | GGPeps | GGPE-2604-X3153 | VendorInvestigate | 2026-Q2 | 98.16 | 5.83 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042074 | Tirzepatide | HYB | HYB-2509-J7103 | Janoshik | 2026-Q1 | 98.31 | 3.93 | 98.4 | Buyer-sourced | 0 | PASS |
| AX-2026-042659 | Semaglutide | SWB | SWB-2602-W8156 | Janoshik | 2026-Q1 | 99.56 | 6.29 | 92.4 | Buyer-sourced | 0 | PASS |
| AX-2025-020388 | Semaglutide | MKM | MKM-2507-D4229 | Janoshik | 2025-Q4 | 99.04 | 5.31 | 94.9 | Buyer-sourced | 0 | PASS |
| AX-2025-019250 | CJC-1295 (no DAC) | AMB | AMB-2507-S5238 | Kestrel | 2025-Q3 | 99.93 | 5.58 | 88.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020701 | CJC-1295 (no DAC) | SGN | SGN-2412-L9210 | Janoshik | 2025-Q2 | 99.36 | 4.89 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020887 | 5-Amino-1MQ | WXT | WXT-2505-M2430 | Janoshik | 2025-Q2 | 98.19 | 2.78 | — | Buyer-sourced | 0 | FAIL |
| AX-2024-004189 | Kisspeptin-10 | WWB | WWB-2311-T3203 | Janoshik | 2024-Q2 | 99.92 | 6.38 | — | Buyer-sourced | 0 | PASS |